Ah receptor:: Dioxin-mediated toxic responses as hints to deregulated physiologic functions

被引:254
作者
Bock, Karl Walter [1 ]
Koehle, Christoph [1 ]
机构
[1] Univ Tubingen, Inst Pharmacol & Toxicol, Dept Toxicol, Tubingen, Germany
关键词
aryl hydrocarbon receptor; dioxin receptor; physiologic responses; toxic responses; carcinogenesis;
D O I
10.1016/j.bcp.2006.01.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor and member of the bHLH/PAS (basic Helix-Loop-Helix/Per-Arnt-Sim) family of chemosensors and developmental regulators. it represents a multifunctional molecular switch regulating endo- and xenobiotic metabolism as well as cell proliferation and differentiation. Physiologic functions of the AhR are beginning to be understood, including functions in vascular development, and in detoxification of endo- and xenobiotics. The AhR is also recognized as the culprit for most toxic responses observed after exposure to dioxins and related compounds such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). The non-metabolizable AhR agonist TCDD has to be distinguished from the myriad of metabolizable agonists present as dietary contaminants and plant constituents as well as endogenous toxins. The hypothesis is emerging that the diverse tissue-specific, TCDD-mediated toxicities are due to sustained and inappropriate AhR activation leading to deregulated physiologic functions. In support of this hypothesis recent observations in the context of some TCDD-mediated toxic responses are discussed, such as chloracne, cleft palate, thymus involution and in particular carcinogenesis. Major open questions are addressed, such as ligand-independent AhR activation by phosphorylation and the large differences in species-dependent susceptibility to toxic responses. Though important issues remain unresolved, the commentary is intended to stimulate efforts to understand dioxin-mediated toxic responses with emphasis on carcinogenesis in comparison with AhR-mediated physiologic functions. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:393 / 404
页数:12
相关论文
共 114 条
[1]   COMPARISONS OF THE EFFECTS OF TCDD AND HYDROCORTISONE ON GROWTH-FACTOR EXPRESSION PROVIDE INSIGHT INTO THEIR INTERACTION IN THE EMBRYONIC MOUSE PALATE [J].
ABBOTT, BD ;
HARRIS, MW ;
BIRNBAUM, LS .
TERATOLOGY, 1992, 45 (01) :35-53
[2]   DEVELOPMENTAL EXPRESSION OF 2 MEMBERS OF A NEW CLASS OF TRANSCRIPTION FACTORS .1. EXPRESSION OF ARYL-HYDROCARBON RECEPTOR IN THE C57BL/6N MOUSE EMBRYO [J].
ABBOTT, BD ;
BIRNBAUM, LS ;
PERDEW, GH .
DEVELOPMENTAL DYNAMICS, 1995, 204 (02) :133-143
[3]   TCDD EXPOSURE OF HUMAN EMBRYONIC PALATAL SHELVES IN ORGAN-CULTURE ALTERS THE DIFFERENTIATION OF MEDIAL EPITHELIAL-CELLS [J].
ABBOTT, BD ;
BIRNBAUM, LS .
TERATOLOGY, 1991, 43 (02) :119-132
[4]  
Andreola F, 1997, CANCER RES, V57, P2835
[5]   Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of β-catenin-mutated mouse liver tumors [J].
Aydinlik, H ;
Nguyen, TD ;
Moennikes, O ;
Buchmann, A ;
Schwarz, M .
ONCOGENE, 2001, 20 (53) :7812-7816
[6]   2,3,7,8-tetrachlorodibenzo-p-dioxin blocks androgen-dependent cell proliferation of LNCaP cells through modulation of pRB phosphorylation [J].
Barnes-Ellerbe, S ;
Knudsen, KE ;
Puga, A .
MOLECULAR PHARMACOLOGY, 2004, 66 (03) :502-511
[7]   Association between aryl hydrocarbon receptor genotype and survival in soft tissue sarcoma [J].
Berwick, M ;
Matullo, G ;
Song, YS ;
Guarrera, S ;
Dominguez, G ;
Orlow, I ;
Walker, M ;
Vineis, P .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) :3997-4001
[8]   Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor [J].
Bittinger, MA ;
Nguyen, LP ;
Bradfield, CA .
MOLECULAR PHARMACOLOGY, 2003, 64 (03) :550-556
[9]   2,3,7,8-tetrachlorodibenzo-p-dioxin-induced activation of a protein tyrosine kinase, pp60(src), in murine hepatic cytosol using a cell-free system [J].
Blankenship, A ;
Matsumura, F .
MOLECULAR PHARMACOLOGY, 1997, 52 (04) :667-675
[10]   Coordinate regulation of drug metabolism by xenobiotic nuclear receptors:: UGTs acting together with CYPs and glucuronide transporters [J].
Bock, KW ;
Köhle, C .
DRUG METABOLISM REVIEWS, 2004, 36 (3-4) :595-615